ATE145728T1 - Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten - Google Patents

Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten

Info

Publication number
ATE145728T1
ATE145728T1 AT93903564T AT93903564T ATE145728T1 AT E145728 T1 ATE145728 T1 AT E145728T1 AT 93903564 T AT93903564 T AT 93903564T AT 93903564 T AT93903564 T AT 93903564T AT E145728 T1 ATE145728 T1 AT E145728T1
Authority
AT
Austria
Prior art keywords
carcinoma
patient
estimating
biopsy
potential
Prior art date
Application number
AT93903564T
Other languages
English (en)
Inventor
Of Washington University
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE145728T1 publication Critical patent/ATE145728T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT93903564T 1992-01-15 1993-01-15 Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten ATE145728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82112092A 1992-01-15 1992-01-15

Publications (1)

Publication Number Publication Date
ATE145728T1 true ATE145728T1 (de) 1996-12-15

Family

ID=25232578

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93903564T ATE145728T1 (de) 1992-01-15 1993-01-15 Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten

Country Status (11)

Country Link
US (2) US5688694A (de)
EP (1) EP0643839B1 (de)
JP (1) JPH07503069A (de)
AT (1) ATE145728T1 (de)
AU (1) AU673153B2 (de)
CA (1) CA2128031A1 (de)
DE (1) DE69306250T2 (de)
ES (1) ES2095038T3 (de)
FI (1) FI943355A (de)
NO (1) NO942653L (de)
WO (1) WO1993014407A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595948A3 (de) * 1999-03-05 2006-03-01 Mitsubishi Rayon Co., Ltd. Träger mit einer biologischen Substanz
JP2003520830A (ja) * 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
CA2428062A1 (en) 2000-11-06 2002-05-10 Board Of Regents, The University Of Texas System Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
US6993175B2 (en) * 2001-09-07 2006-01-31 Quest Diagnostics Investments Incorporated Methods for measuring microvascular density in tumors
US7229423B2 (en) * 2003-02-05 2007-06-12 Timi 3 System, Inc Systems and methods for applying audible acoustic energy to increase tissue perfusion and/or vasodilation
US20070100335A1 (en) * 2005-10-28 2007-05-03 Apple Medical Corporation Instrument for electrosurgical excision procedure for the uterine cervix
US8321010B2 (en) * 2009-09-04 2012-11-27 Konstantin Georgievich Korotkov Method for determining the condition of a biological object and device for making same
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0553273A4 (en) * 1990-10-16 1998-04-22 Biomed Frontiers Inc Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging

Also Published As

Publication number Publication date
AU3478293A (en) 1993-08-03
DE69306250D1 (de) 1997-01-09
WO1993014407A1 (en) 1993-07-22
FI943355A0 (fi) 1994-07-14
CA2128031A1 (en) 1993-07-22
NO942653D0 (no) 1994-07-14
AU673153B2 (en) 1996-10-31
NO942653L (no) 1994-09-12
EP0643839A1 (de) 1995-03-22
DE69306250T2 (de) 1997-03-20
EP0643839B1 (de) 1996-11-27
FI943355A (fi) 1994-09-14
ES2095038T3 (es) 1997-02-01
US5616469A (en) 1997-04-01
JPH07503069A (ja) 1995-03-30
US5688694A (en) 1997-11-18

Similar Documents

Publication Publication Date Title
ATE130104T1 (de) Verfahren zur bestimmung von hdl-cholesterin mittels eines schnelldiagnostikums mit integriertem fraktionierschritt.
EP1743939A3 (de) Verfahren zur Isolierung von RNA aus Formalin-fixierten Paraffin-eingebetteten Gewebeproben
EP1496350A3 (de) Verfahren und Vorrichtung zum Erzeugen von Basissätzen für Spektralanalyse
EP1254630A3 (de) Verfahren, Vorrichtung und Computerprogramm zur Bestimmung des Blutflusses in einer Gewebe- oder Organregion
ATE145728T1 (de) Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
DE59009364D1 (de) Verfahren zur quantitativen Bestimmung zumindest eines chemischen Parameters eines Probenmediums.
DE50105971D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
ATE220209T1 (de) Diagnostisches verfahren zur bestimmung der ätiologie entzündlicher prozesse
ATE130100T1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
RU2007148219A (ru) Способ обнаружения бактерий и тест-набор для их обнаружения
ATE212727T1 (de) Ein verfahren zur bestimmung der konzentration von sauerstoff in einer probe
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
DE3585562D1 (de) Verfahren zur optischen untersuchungsanalyse von integrierten schaltungen.
DE69719091T2 (de) Verfahren zur objektivierung von subjektiven klassifizierungen
Skog Loxsomopteris anasilla, a new fossil fern rhizome from the Cretaceous of Maryland
DE69008690D1 (de) Verfahren und Vorrichtung zur Bestimmung von aeroben Bakterien.
EP1039394A3 (de) Verfahren und Anordnung zur Datenauswertung
Marshall Interior Rim Impressions as an Indicator of Typological Relationships
ATE458813T1 (de) Verfahren zur bestimmung von ctp11 sowie zur bestimmung des metastatischen potentials einer tumor probe
DE3769560D1 (de) Verfahren zur ermittlung von kernmagnetischen spektren aus raeumlich selektierbaren bereichen eines untersuchungsobjektes.
Orser et al. Using Ari Kara Osteological Data To Evaluate An Assumpti on oF Fur Trade Archaeology
Grant Right Place, Time and Technique: Right Sample.
Balbi et al. Method for the Determination of Nonmetallic Inclusions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties